Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
Phase 2
Completed
- Conditions
- Social Anxiety Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- EmpowerPharm Inc.
- Target Recruit Count
- 239
- Registration Number
- NCT05600114
- Locations
- 🇺🇸
EPI-CBD-001-Site, Rochester, New York, United States
🇺🇸EPI-CBD-001 Site, Bellevue, Washington, United States
🇺🇸EPI-CBD-001 site, Wichita Falls, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath